Zetia Uses
Links shared publicly online about this topic
MediGuard.org - Zetia
mediguard.org — “MediGuard.org - Zetia” View full resource at mediguard.org
Most Recently Shared on January 31, 2011 at 6:17 pm By:
MediGuard.org Health Organization
100% of patients taking #zetia use it for High Cholesterol ... http://tinyurl.com/47ryqx7
Questions raised about Zetia in new study
healthcentral.com — “Questions raised about Zetia in new study” View full resource at healthcentral.com
Most Recently Shared on November 17, 2009 at 9:42 pm By:
CholesterolNetwork: Questions raised about Zetia in new study http://bit.ly/32p4ld Full http://bit.ly/nk8J0
Health News Blog » Niacin Zings Zetia
naturalhealthontheweb.com — “Use no more than 255 characters” View full resource at naturalhealthontheweb.com
Most Recently Shared on November 23, 2009 at 4:13 am By:
Arthur M. Healthy Eating Advisor
Reading: "Blogs » Niacin Zings Zetia" (http://twitthis.com/u8n4oh)
Cheap Niacin Beats Pricier Zetia in Heart Patients - ABC News
abcnews.go.com — “Results reported here Sunday may not put the nail in the coffin for a once wildly popular cholesterol-lowering drug, but they do put Zetia at the bottom of the list of medications that doctors will be using.” View full resource at abcnews.go.com
Most Recently Shared on November 16, 2009 at 4:14 pm By:
Evelyn Tribole Nutritionist, Dietitian, and Active Health Library
Cheap Niacin Beats Pricier Statin (Zetia ) in Heart Patients - ABC News http://bit.ly/3LNmtj
New Study Raises New Questions About Cholesterol Drug Zetia - Drugs.com MedNews
drugs.com — “A new study raises more questions about ezetimibe (Zetia), a drug used by millions of Americans in tandem with statins to lower LDL, or bad, cholesterol. The tr” View full resource at drugs.com
Most Recently Shared on November 16, 2009 at 6:10 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia - http://bit.ly/ufFTI
New Study Raises New Questions About Cholesterol Drug Zetia - US News and World Report
health.usnews.com — “It was found less effective than extended-release niacin, or Niaspan” View full resource at health.usnews.com
Most Recently Shared on November 16, 2009 at 3:32 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia - U.S. News & World Report http://ow.ly/1622kj
Study Raises New Questions About Cholesterol Drug Zetia - myOptumHealth
myoptumhealth.com — “Read the news article Study Raises New Questions About Cholesterol Drug Zetia at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on November 16, 2009 at 12:08 pm By:
New Study Raises New Questions About Cholesterol Drug Zetia: It was found less effective than extended-release niac... http://bit.ly/28oBWa
Don't stop taking your Zetia yet! - San Francisco SF | Examiner.com
examiner.com — “There has been a flurry of activity on the internet regarding the lipid lowering agent Zetia. Zetia, or ezetimibe, is a medication that is used in people who” View full resource at examiner.com
Most Recently Shared on November 18, 2009 at 3:35 pm By:
Don’t stop taking your Zetia yet! - http://tinyurl.com/yjneyzx Take a look, pass it on.
Follow-Up to the August 2008 Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia) - FDA Investigates a Report from the SEAS Trial
fda.gov — “In august 2008, the u.s. food and drug administration (fda) issued an early communication describing a possible association between the use of vytorin – a combination of simvastatin (zocor) and ezetimibe (zetia) – and an increased risk of cancer and cancer-related death compared to placebo.” View full resource at fda.gov
Most Recently Shared on December 22, 2009 at 4:31 pm By:
eyeonfda Pharma and Health Lawyer
RT @FDA_Drug_Info: Follow-Up to the Aug. 2008 Early Communication on Vytorin, Zetia, Zocor and the SEAS Trial. http://bit.ly/FU_SEAS
Comments of migraine in the use of Crestor - eHealthMe.com
ehealthme.com — “I currently taking crestor and zetia to lower my cholestoral 10mg each. But every since i have been taking them I have been getting these horible migraines every single day. no over the counter meds have helped. I have been taking the meds for a yr now and I never had a problem until i refilled. I am wondering if i got a bad bottle. because it is horrible..” View full resource at ehealthme.com
Most Recently Shared on March 15, 2012 at 10:31 pm By:
I currently taking crestor and zetia to lower my cholestoral 10mg each. But every since i have been taking the http://t.co/C361xTDu
70% Of Physicians on Sermo State They Would Increase Their Use of Niacin Based on the ARBITER 6-HALTS Trial
businesswire.com — “CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sermo (http://www.sermo.com), the world's largest online physician's community, today announced the results of a new report indicating that 70% of 350 US physician respondents would increase their use of niacin based on results from the ARBITER 6-HALTS trial. The head-to-head trial demonstrated the superiority of extended-release niacin (Abbott) over ezetimibe (Merck’s Zetia) when combined with statin therapy. This data is part of Sermo’s ne” View full resource at businesswire.com
Most Recently Shared on December 1, 2009 at 1:59 pm By:
Sermo Team Health Social Media
"70% Of Physicians on Sermo State They Would Increase Their Use of Niacin Based on the ARBITER 6-HALTS Trial" http://tinyurl.com/ygvbge3
70% Of Physicians on Sermo State They Would Increase Their Use of Niacin Based on the ARBITER 6-HALTS Trial | Business Wire
businesswire.com — “CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sermo (http://www.sermo.com), the world's largest online physician's community, today announced the results of a new report indicating that 70% of 350 US physician respondents would increase their use of niacin based on results from the ARBITER 6-HALTS trial. The head-to-head trial demonstrated the superiority of extended-release niacin (Abbott) over ezetimibe (Merck’s Zetia) when combined with statin therapy. This data is part of Sermo’s ne” View full resource at businesswire.com
Most Recently Shared on December 2, 2009 at 3:03 pm By:
Fabio Gratton Health Social Media and Health Executive
Sermo publishes first report of new "FirstLine" series, revealing 70% of HCPs wld increase Niacin use based on trial data: http://tr.im/GpSJ
FDA allows Vytorin labeling for use in kidney disease, but not new indication
nephrologynews.com — “FDA did not approve a new indication for Vytorin or for Zetia” View full resource at nephrologynews.com
Most Recently Shared on January 27, 2012 at 3:56 pm By:
Nephrology News Health News and Nephrology
FDA allows Vytorin labeling for use in kidney disease, but not new indication http://t.co/oMlX4LMD
FDA to Explore Possible Vytorin-Cancer Link
webmd.com — “The FDA is investigating a report from the SEAS trial of a possible association between use of the drug Vytorin and increased cancer risk.” View full resource at webmd.com
Most Recently Shared on August 22, 2008 at 2:22 am By:
WebMD Health News FDA to Explore Possible Vytorin-Cancer Link: The FDA is investigati.. http://tinyurl.com/6nqy3r
RxEconsult, LLC - Vytorin (ezetimibe/simvastatin) for cholesterol reduction
rxeconsult.com — “RxEconsult, LLC - Vytorin (ezetimibe/simvastatin) for cholesterol reduction” View full resource at rxeconsult.com
Most Recently Shared on September 20, 2011 at 11:58 am By:
RxEconsult. If you are in need of healthcare services or information, please visit RxEconsult.
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
Arthur M.
Internet entrepreneur with interests in Internet marketing, various areas of health and fitness. Maintain several web sites and blogs on these topics.
Advertisement
